Opening Lecture: “The evolution of knowledge mobilization at CIHR”

Dr. Michael Strong: The evolution of knowledge mobilization at CIHR

View Presentation


Zoom Link A: Please click the link below to join the webinar:

Passcode: 66892


Or One tap mobile: 

Canada: +16473744685,,95219788376#  or +16475580588,,95219788376# 

Or Telephone:

Dial(for higher quality, dial a number based on your current location):

Canada: +1 647 374 4685  or +1 647 558 0588 

Webinar ID: 952 1978 8376

International numbers available:

Or an H.323/SIP room system:

H.323: (US West) (US East) (Amsterdam Netherlands) (Germany) (Australia Sydney) (Australia Melbourne) (Canada Toronto) (Canada Vancouver)
Meeting ID: 952 1978 8376



May 05 2021


12:15 pm - 12:45 pm

Local Time

  • Timezone: America/New_York
  • Date: May 05 2021
  • Time: 12:15 pm - 12:45 pm




  • Dr. Michael Strong
    Dr. Michael Strong
    Canadian Institutes of Health Research

    Michael J. Strong became the President of the Canadian Institutes of Health Research in October, 2018. Prior to this, he served as the Dean of the Schulich School of Medicine & Dentistry at Western University where he continues to hold an appointment as a Distinguished University Professor and a Scientist at the Robarts Research Institute. He undertook his medical training at Queens University in Kingston (1976 – 1982), neurology training at Western University (1982 – 1987), and postgraduate training at the Laboratory of Central Nervous System Studies (director – D. Carleton Gadjusek, Nobel Laureate) at the National Institutes of Health, Bethesda, Maryland under the supervision of Ralph M. Garruto, PhD (1987 – 1990). He has published over 195 peer-reviewed articles and 29 chapters, edited 4 textbooks and given over 170 invited lectures nationally and internationally related to his research in ALS. Dr. Strong was awarded the Sheila Essay Award in 2005 and the Forbes Norris Award in 2008, and is the only Canadian to have received both international awards for ALS research. He was elected as a fellow of the American Academy of Neurology in 2008. In 2009, he was elected a Fellow of the Canadian Academy of Health Sciences. His research has focused on understanding the cellular biology of ALS (Lou Gehrig’s disease) including the role of altered RNA metabolism in the genesis of neuronal cytoplasmic inclusions and in the clinicopathological correlates of the frontotemporal spectrum disorder that can be associated with ALS. The latter has led to an appreciation for the role of alterations in tau protein metabolism in ALS.

Leave a Reply

Your email address will not be published. Required fields are marked *